Treatment of Failing Blebs With Ranibizumab

Part of paid clinical trials in New York, New York.

Sponsor
The New York Eye & Ear Infirmary
Study ID
NCT00570726
Phase
PHASE1
Status
Completed

Conditions

  • Failing Bleb Following Trabeculectomy
  • Glaucoma, Open-Angle

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This study was designed to evaluate the efficacy and safety in the use of Ranibizumab, an effective vascular endothelial growth factor (VGEF) inhibitor, in treating patients with a failing bleb, characterized by increased fibrosis and vascularization of the conjuctiva, following trabeculectomy. Six subjects from one site will be enrolled in this study.

Key Dates

First listed
Dec 11, 2007
Start date
Jun 30, 2000
Status verified
Dec 2007
Primary completion
Nov 30, 2007
Completion
Nov 30, 2007

Study Design

Enrollment
6 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Glaucoma Associates of New YorkNew YorkNew York10003-

Find similar trials in New York, NY

By research site
Glaucoma Associates of New York· New York, NY

Related Studies